Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Ensign Group (ENSG) Takes Shareholder-Friendly Initiatives

Published 12/18/2019, 11:32 PM
Updated 07/09/2023, 06:31 AM

In an effort to enhance shareholder value, the board of directors of The Ensign Group, Inc. (NASDAQ:ENSG) has proposed a 5.3% increase in the quarterly dividend of 4.75 cents per share. This translates to a yearly dividend payment of 5 cents per share. Shareholders of record on Dec 31, 2019 are expected to receive this meatier dividend on or before Jan 31, 2019.

Ensign Group has been paying dividends since 2002 and has increased its payouts every year. This marks the 17th straight year of dividend raises by the company. Its track record of disbursing excess capital to investors remains impressive. The improved dividends not only bear testimony to the operational and financial strength of Ensign Group but also make the stock attractive for yield-seeking investors.

The company is well poised for growth and is eyeing greater prospects, which would help it continue to boost shareholder value. Its solid financial footing underlines its confidence in this regard. The dividend hike is indicative of the bullish investor sentiment and should further cement the company’s position to taste success in both the near and long term.

Its current dividend yield stands at 1.6%, much higher than its industry's average of 0.9%.

Frequent share repurchases and dividend payments at regular intervals enabled the company to retain investor confidence in the stock that bodes well. Maintenance of capital resources at sufficient levels will provide flexibility to future business growth.

Ensign Group has been witnessing a steady rise in revenues on the back of its Medicaid and Medicare businesses, Transitional & Skilled Services growth strategies and acquisitions. We expect the company's solid businesses to consistently support its dividend payment trend going forward.

Shares of this Zacks Rank #4 (Sell) company have gained 14% in the past year against its industry’s dip of 1.9%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .



Stocks to Consider

Investors interested in the medical sector might consider some better-ranked stocks like Select Medical Holdings Corporation (NYSE:SEM) , WellCare Health Plans, Inc. (NYSE:WCG) and Genesis Healthcare, Inc. (NYSE:GEN) . You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Select Medical Holdings operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics and occupational health centers. In the trailing four quarters, the company’s average beat was 11.07%. The stock sports a Zacks Rank #1.

WellCare Health offers managed care services to government-sponsored health care programs. The company pulled off average positive surprise of 17.32% in the preceding four quarters. It carries a Zacks Rank #2 (Buy).

Genesis Healthcare operates skilled nursing facilities and assisted/senior living homes. In the last four quarters, the company delivered average beat of 80.96%. It has a Zacks Rank of 1.

Biggest Tech Breakthrough in a Generation

Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.

A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft (NASDAQ:MSFT) in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.

See 8 breakthrough stocks now>>



Select Medical Holdings Corporation (SEM): Free Stock Analysis Report
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


WellCare Health Plans, Inc. (WCG): Free Stock Analysis Report

The Ensign Group, Inc. (ENSG): Free Stock Analysis Report

Genesis Healthcare, Inc. (GEN): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.